Chronicle Issues
  Research Review Issues
  CFIDSLink
E-newsletter
  Reprint Policies

RETURN TO TABLE OF CONTENTS
Fall 2003

Research Briefs

Exercise test could yield CFS marker
Exercise challenge in people with chronic fatigue syndrome (CFS) appears to lead to increased production of a specific immune system protein — a finding that could lead to a diagnostic marker for the illness.

Researchers at the National Jewish Medical and Research Center and the University of Colorado looked at post-exercise immune changes in 32 CFS patients and 29 age-matched, normal control subjects. Both groups exercised for 20 minutes on stationary bicycles at 70 percent of their predicted maximum work loads. Blood samples were taken prior to exercise, and additional samples were collected at four intervals after the test was completed.

A significant increase in the split complement protein C4a was detected in the CFS group at the six-hour post-exercise measuring point. Com-plement proteins are a key component of the immune system response; they perform tasks ranging from stimulation of phagocytosis to initiating inflammation and B-cell activation.

In normal subjects, C4a generation is only stimulated at much higher exercise levels, and levels return to normal within three hours of the cessation of exercise.

The authors note that the exercise challenge allowed them to study CFS patients in an exacerbated state of illness. It is worth mentioning that the patients showed significant increases in symptoms following the challenge; this is consistent with post-exertional relapse, a hallmark symptom of CFS. Symptom diaries revealed significant increases in "reduced activity" and "mental fatigue" after the exercise challenge; the control subjects reported no adverse effects as a group.

The increases in C4a also correlated with the post-exercise symptom reports. The authors state: "The detection of this single protein (C4a) after exercise in conjunction with increased symptoms makes the development of a diagnostic test with an exercise challenge a real possibility."

Sorensen B et al. "Complement activation in a model of chronic fatigue syndrome." J Allergy Clin Immunol. Aug 2003; 112:397-403.


Muscle structures altered in patients with CFS
Rapid muscle fatigue and ensuing muscle pain are hallmarks of CFS. A new study from Italy has found more support for the hypothesis that altered structures within muscles may play a role in the development of these symptoms.

Researchers examined biopsied samples of striated muscle from four CFS patients and four other subjects with fibromyalgia, looking specifically at sarcoplasmic reticulum (SR) membranes. These structures release calcium ions that induce muscle contraction, and also re-absorb the ions to elicit muscle relaxation.

The authors report increased fluidity in the SR membranes (confirming earlier results). This could result in changes in the flow of ions across the membranes. In addition, there are also changes in the actions of dihydropyridine receptors, which control the release of calcium ions. Other changes noted affect the activity of enzymes that catalyze the release and re-absorption of calcium ions.

Many of these changes mimic the behavior of muscles in aging people. The authors speculate that oxidative tissue damage may occur at an increased rate in CFS patients, a phenomenon that has been reported in other research.

Fulle S et al. "Modi-fication of the functional capacity of sarcoplasmic reticulum membranes in patients suffering from chronic fatigue syndrome." Neuromuscu-lar Disorders. 2003; 13:479-484.

Another study from New York Medical College and Washington State University related to oxidative stress finds that protein carbonyl levels — a measure of overall protein oxidation — were significantly higher in the sera of patients with CFS when compared to control subjects. The total protein levels in the patients, by contrast, were similar to controls. The authors state that the findings are consistent with the theory that elevated nitric oxide/peroxynitrite levels play a role in CFS pathology.

Smirnova IV et al. "Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients." Mol Cell Biochem. Jun 2003; 248(1-2): 93-5.


Reaction times linked to motor deficits in CFS
Along with muscle fatigue, patients with CFS often exhibit slower simple reaction times (SRT) and simple movement times (SMT). New research from Imperial College in London shows that this phenomenon may be related to deficits in the motor preparatory areas of the brain, according to a study published in The International Journal of Clinical Practice.

The study’s authors tested 10 CFS patients twice over a period of two years, measuring both SRT and SMT. Transcranial magnetic stimulation was applied to the palms of test subjects to measure the level of corticospinal excitability at the times of the tests.

The results show that corticospinal excitability often varied in subjects from one testing period to the other. This variability correlated with changes in SRT and SMT; the more stimulus required to provoke corticospinal excitability, the lower the overall reaction time scores. The authors say their work "provides evidence that the changing motor deficits in CFS have a neurophysical basis."

Davey NJ et al. "Deficit in motor performance correlates with changed corticospinal excitability in patients with chronic fatigue syndrome." Int J Clin Pract. 2003; 57(4): 262-264.


REM sleep differs in CFS subjects
Patients with CFS appear to have a higher percentage of rapid-eye movement (REM) sleep than their non-CFS mono-zygotic twins, according to research from the Univer-sity of Washington.

Twenty-two sets of CFS-discordant twins were used in the study. All subjects completed the Sleep Disorders Questionnaire prior to the testing, and then were given continuous polysomnography tests, which measure physiological activity during sleep. A post-polysomnography survey also was completed by each of the participants.

The twin pairs did not differ significantly on most objective measures of sleep, including total sleep time, sleep efficiency and percentage of Stage 1, 2 or 3-4 (delta) sleep. However, the CFS twin showed statistically significant increases in the percentage of REM sleep compared to the non-CFS twin (27.7% of overall sleep vs. 24.4%).

On the post-test survey, the CFS twins generally reported worse subjective results, including sleeping fewer hours (6.2 vs. 6.7) and feeling less well rested. Because the subjective reports did not match the objective findings, the authors suggest that the CFS patients "suffer from an element of sleep-state misperception." The higher percentage of REM sleep in the CFS twins may play an unknown role in this phenomenon, and in the illness in general, according to the study.

Watson NF et al. "Comparison of subjective and objective measures of insomnia in monozygotic twins discordant for chronic fatigue syndrome." Sleep. 2003; 26(3): 324-8.


Exercise test could stratify CFS patients
CFS research efforts are complicated by the heterogeneity of the patient population. Attempts are being made to stratify patient groups based on a number of factors, from immune system anomalies to severity and onset of illness. A new study from the University of the Pacific points to exercise testing results as a possible means to stratify patients in hopes of better studying and treating them.

The study looks at 189 people with CFS, ranging in age from 19 to 60 years. All were recruited for another study on the efficacy of the immunomodulatory drug Ampligen. The patients were tested on a treadmill, with increasing difficulty settings over a 22-minute period, and asked to continue until they felt they could no longer maintain their position on the device.

Results show that nearly half the subjects tested (n=92) were classified under American Medical Association guidelines as having moderate to severe functional impairment. Worth noting is that 10 percent of subjects showed no impairment and 35 percent showed mild impairment. Multiple measurements factor into the AMA classifications, including peak and predicted VO2.

Three other measurements reached statistical significance when differentiating the four subgroups: peak heart rate, peak systolic blood pressure and total respiratory quotient. Peak heart rate was lower in groups that showed more impairment, as was peak systolic blood pressure. The authors note that the blunted heart rate and blood pressure responses are similar to those found in patients with chronic heart failure (an exclusionary criteria in the current study).

Gender differences also were apparent. A higher percentage of women than men fell into the moderate and severe categories. But the women in these groups consistently achieved a peak VO2 level that was closer to the maximal predicted levels. The authors say these gender differences warrant further study.

Exercise testing may eventually help clinicians determine the etiology and pathogenesis of individual cases of CFS, the authors note. Because each category displayed unique cardiovascular profiles, cardiac autonomic dysfunction could play a role in some CFS cases. But the authors say that other factors, ranging from neuroendocrinological or metabolic function to postviral immune system activation, could also be factors in the exercise test results.

Vanness JM et al. "Subclassifying Chronic Fatigue Syndrome through Exercise Testing." Med Sci Sports Exerc. 2003; 35(6): 908-13.